These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 18306415)

  • 81. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
    Huo TI; Lin HC; Hsia CY; Huang YH; Wu JC; Chiang JH; Chiou YY; Lui WY; Lee PC; Lee SD
    Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
    [TBL] [Abstract][Full Text] [Related]  

  • 82. A new liver transplant priority for patients with hepatocellular carcinoma.
    Ravaioli M; Grazi GL; Vetrone G; Kimura T; Zanello M; Ercolani G; Cescon M; Varotti G; Del Gaudio M; Tuci F; Cucchetti A; La Barba G; Vivarelli M; Lauro A; Ramacciato G; Pinna AD
    Hepatogastroenterology; 2008; 55(86-87):1742-5. PubMed ID: 19102382
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Accuracy of capillary whole blood international normalized ratio on the CoaguChek S, CoaguChek XS, and i-STAT 1 point-of-care analyzers.
    Karon BS; McBane RD; Chaudhry R; Beyer LK; Santrach PJ
    Am J Clin Pathol; 2008 Jul; 130(1):88-92. PubMed ID: 18550476
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Predicting prognosis in patients with end-stage liver disease.
    Ebell MH
    Am Fam Physician; 2006 Nov; 74(10):1762-3. PubMed ID: 17137008
    [No Abstract]   [Full Text] [Related]  

  • 85. Value of the model for end-stage liver disease for predicting survival in hepatocellular carcinoma patients treated with transarterial chemoembolization.
    Kim JH; Kim JH; Choi JH; Kim CH; Jung YK; Yim HJ; Yeon JE; Park JJ; Kim JS; Bak YT; Byun KS
    Scand J Gastroenterol; 2009; 44(3):346-57. PubMed ID: 18991165
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Consequences of abnormal hemostasis tests for clinical practice.
    Lisman T; Caldwell SH; Porte RJ; Leebeek FW
    J Thromb Haemost; 2006 Sep; 4(9):2062-3. PubMed ID: 16961615
    [No Abstract]   [Full Text] [Related]  

  • 87. Pulmonary embolism.
    Marlar RA; Joist JH; Fink LM
    N Engl J Med; 1998 Nov; 339(21):1556-7. PubMed ID: 9841335
    [No Abstract]   [Full Text] [Related]  

  • 88. Prothrombin time to assess fulminant hepatic failure.
    Newsome PN; Henderson NC; Germain L; Ludlam CA; Simpson KJ
    Lancet; 2001 Dec 22-29; 358(9299):2172. PubMed ID: 11784669
    [No Abstract]   [Full Text] [Related]  

  • 89. Improving Outcomes in Critical Care of Patients With Cirrhosis and Organ Failure: Herding Runaway Horses and Securing the Barn Door.
    Ghabril M
    Clin Gastroenterol Hepatol; 2015 Jul; 13(7):1361-3. PubMed ID: 25681692
    [No Abstract]   [Full Text] [Related]  

  • 90. Guidelines on preparation, certification, and use of certified plasmas for ISI calibration and INR determination--a rebuttal.
    Egberg N; Fagerberg I; Hillarp A; Lindahl TL; Stigendal L
    J Thromb Haemost; 2005 Oct; 3(10):2370-1; author reply 2731-2. PubMed ID: 16194220
    [No Abstract]   [Full Text] [Related]  

  • 91. Standardization of the one-stage prothrombin time.
    Quick AJ
    Thromb Diath Haemorrh; 1972 Feb; 27(1):179-80. PubMed ID: 5033667
    [No Abstract]   [Full Text] [Related]  

  • 92. Hepatic failure.
    Ruiz R
    Clin Pediatr (Phila); 2007 Jan; 46(1):80-1. PubMed ID: 17164516
    [No Abstract]   [Full Text] [Related]  

  • 93. More on: Properties of recombinant human thromboplastins that determine the International Sensitivity Index (ISI).
    Tripodi A; Mannucci PM
    J Thromb Haemost; 2005 Mar; 3(3):612-3. PubMed ID: 15748271
    [No Abstract]   [Full Text] [Related]  

  • 94. [New concept in nomenclature, classification and diagnosis of liver failure].
    Wang YM
    Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):803-4. PubMed ID: 21138623
    [No Abstract]   [Full Text] [Related]  

  • 95. [Standardization of the prothrombin time determination].
    Gibitz HJ
    Wien Z Inn Med; 1968; 49(6):237-40. PubMed ID: 5737585
    [No Abstract]   [Full Text] [Related]  

  • 96. [Rapid calculation of the prothrombin index by the method of G. Ia. Gorodisska].
    Rozenblit IaA
    Lab Delo; 1966; 9():563-5. PubMed ID: 4176136
    [No Abstract]   [Full Text] [Related]  

  • 97. [Report on standardization of the Quick time].
    De Nicola P
    Haematol Lat; 1968 Sep; 11():Suppl 3:7-14. PubMed ID: 5742213
    [No Abstract]   [Full Text] [Related]  

  • 98. Coagulation proteins influencing global coagulation assays in cirrhosis: hypercoagulability in cirrhosis assessed by thrombomodulin-induced thrombin generation assay.
    Youngwon N; Kim JE; Lim HS; Han KS; Kim HK
    Biomed Res Int; 2013; 2013():856754. PubMed ID: 23555099
    [TBL] [Abstract][Full Text] [Related]  

  • 99. How to implement the modified international normalized ratio for cirrhosis (INR(liver)) for model for end-stage liver disease calculation.
    Tripodi A
    Hepatology; 2008 Apr; 47(4):1423-4; author reply 1424. PubMed ID: 18306415
    [No Abstract]   [Full Text] [Related]  

  • 100. A modified international normalized ratio as an effective way of prothrombin time standardization in hepatology.
    Bellest L; Eschwège V; Poupon R; Chazouillères O; Robert A
    Hepatology; 2007 Aug; 46(2):528-34. PubMed ID: 17654598
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.